Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools-Reference-Cited by-同舟云学术

Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools

Published:2016-11-15 Issue:4 Volume:4 Page:25
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Ljungberg Michael,Sjögreen Gleisner Katarina

Funder

Swedish Research Council

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Link

http://www.mdpi.com/2227-9059/4/4/25/pdf

Reference51 articles.

1. Report 86: Quantification and reporting of low-dose and other heterogeneous exposures;J. ICRU,2011

2. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy

3. Patient-specific dosimetry in predicting renal toxicity with 90Y-DOTATOC: Relevance of kidney volume and dose rate in finding a dose-effect relationship;Barone;J. Nucl. Med.,2005

4. MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy

5. Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment;Annals of Nuclear Medicine;2024-07-18

2. Accuracy of patient-specific I-131 dosimetry using hybrid whole-body planar-SPECT/CT I-123 and I-131 imaging;EJNMMI Physics;2024-06-20

3. Targeted Treatment of Various Cancers using Radionuclide: Advancement and Prospective;Current Cancer Therapy Reviews;2024-05-31

4. Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium;Frontiers in Nuclear Medicine;2024-03-28

5. A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry;Frontiers in Oncology;2024-02-26